2024年至2032年医疗冷链储存设备市场机会、成长动力、产业趋势分析与预测

2023年，全球医疗冷链储存设备市场价值为29亿美元，预计2024年至2032年复合年增长率为5.3%。冷链储存在确保疫苗和生物製剂等温度敏感医疗产品的安全运输和储存方面发挥着至关重要的作用。技术进步正在重塑冷链仓储产业。物联网 (IoT) 技术的整合可以即时监控温度和湿度水平，确保产品在整个供应链中保持最佳状态。

此外，区块链技术正在探索增强可追溯性和透明度，有助于防止假冒产品并确保药品的真实性。然而，先进技术和基础设施的高昂初始成本构成了挑战，特别是对于小型公司和发展中市场而言。如果管理不当，与温度控制、运输和法规遵循相关的复杂物流可能会导致效率低下。此外，冷储存对稳定电源的依赖使其容易受到电网故障或自然灾害的干扰，从而损害产品的完整性。

在设备方面，冷冻柜领域2023年产值约为11亿美元，预计2024年至2032年复合年增长率为5.9%。环保冷媒，降低营运成本和环境影响。 2023 年，製药业约占33% 的市场份额，预计到2032 年将以5.6% 的复合年增长率增长。链解决方案。对生物製剂和疫苗储存和运输的监管要求促使製药公司采用尖端设备，包括支援物联网的监控系统，该系统可提供即时资料，以最大限度地减少变质风险。北美在2023 年以32% 的份额引领市场，预计到2032 年将以5.4% 的复合年增长率增长。工作推动的。

FDA 和 CDC 等机构的严格法规要求药品具有精确的储存条件，促使医院和製造商投资于合规设备。此外，物联网和智慧监控系统的进步透过即时追踪和温度偏差自动警报提高了冷链储存的可靠性和效率

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
  • 影响价值链的因素。
  • 利润率分析。
  • 干扰
  • 未来展望
  • 製造商
  • 经销商
• 产业影响力
  • 成长动力
    • 对疫苗和生物製剂的需求不断增加
    • 生物製药产业的成长
  • 产业陷阱与挑战
    • 初期投资高
    • 供应链中断
• 成长潜力分析
• 未来趋势分析
• 价格分析
• 技术景观
• 监理框架
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 公司市占率分析
• 竞争定位矩阵
• 战略展望矩阵

第 5 章：市场估计与预测：按设备类型

• 主要趋势
• 冰箱
  • 实验室冰箱
  • 血库冰箱
  • 药房冰箱
  • 色谱冰箱
• 冰柜
  • 超低温冷冻柜
  • 等离子冷冻机
  • 冷冻柜
• 低温储存系统
  • 液态氮储存系统
  • 气相储存系统
• 凉室
• 其他（冰衬冰箱、太阳能直驱冰箱等）

第 6 章：市场估计与预测：依温度范围

• 主要趋势
• 2°C 至 8°C
• -20°C 至 -40°C
• -40°C 至 -80°C
• -80℃以下

第 7 章：市场估计与预测：按产能

• 主要趋势
• 小号（最多 300 公升）
• 中型（300-700公升）
• 大号（700公升以上）

第 8 章：市场估计与预测：依技术分类

• 主要趋势
• 基于压缩机的系统
• 基于吸收的系统
• 基于热电的系统

第 9 章：市场估计与预测：按应用

• 主要趋势
• 疫苗储存
• 血液及血液製品储存
• 生物样本储存
• 药品及药品储存
• 其他（器官储存、细胞培养基等）

第 10 章：市场估计与预测：依最终用途

• 主要趋势
• 医院和诊所
• 製药公司
• 研究实验室
• 血库
• 药局
• 其他（学术机构、诊断中心等）

第 11 章：市场估计与预测：按地区

• 主要动向：按地区
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
• MEA
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第 12 章：公司简介

• Azenta
• Binder
• Cardinal Health
• Carebios Biological Technology
• Darwin Chambers
• Elanpro
• Farrar
• Haier Biomedical
• Hoshizaki America
• Kendall Cold Chain System
• Memmert
• Philipp Kirsch
• Roemer Industries
• Summit Appliance
• Thalheimer Kuhlung

The Global Medical Cold Chain Storage Equipment Market was valued at USD 2.9 billion in 2023 and is projected to grow at 5.3% CAGR from 2024 to 2032. The rising demand for pharmaceuticals, fueled by medical advancements and an aging population, drives the market growth. Cold chain storage plays a critical role in ensuring the safe transport and storage of temperature-sensitive medical products, such as vaccines and biologics. Technological advancements are reshaping the cold chain storage industry. The integration of Internet of Things (IoT) technology allows for real-time monitoring of temperature and humidity levels, ensuring that products remain within optimal conditions throughout the supply chain.

Additionally, blockchain technology is being explored to enhance traceability and transparency, helping to prevent counterfeit products and ensuring the authenticity of pharmaceuticals. However, high initial costs for advanced technology and infrastructure pose challenges, particularly for smaller companies and developing markets. Complex logistics related to temperature control, transportation, and regulatory compliance can lead to inefficiencies if not properly managed. Moreover, cold storage's reliance on consistent power supplies makes it susceptible to disruptions from grid failures or natural disasters, which can compromise product integrity.

In terms of equipment, the freezer segment generated around USD 1.1 billion in 2023 and is expected to grow at a CAGR of 5.9% from 2024 to 2032. Demand for ultra-low temperature freezers has surged, particularly for vaccine storage, driving innovation in energy-efficient technologies and environmentally friendly refrigerants, reducing both operational costs and environmental impact. The pharmaceutical sector accounted for roughly 33% of the market share in 2023 and is anticipated to grow at a CAGR of 5.6% through 2032. With a growing number of temperature-sensitive drugs, manufacturers are increasingly investing in advanced cold chain solutions. Regulatory requirements for the storage and transport of biologics and vaccines have prompted pharmaceutical companies to adopt cutting-edge equipment, including IoT-enabled monitoring systems that provide real-time data to minimize spoilage risks. North America led the market with a 32% share in 2023 and is expected to grow at a CAGR of 5.4% through 2032. The regional growth is driven by increasing demand for injections and biologics, healthcare infrastructure development, and ongoing R&D efforts.

Strict regulations from authorities like the FDA and CDC require precise storage conditions for pharmaceuticals, pushing hospitals and manufacturers to invest in compliant equipment. Additionally, advancements in IoT and smart monitoring systems are enhancing the reliability and efficiency of cold chain storage through real-time tracking and automated alerts for temperature deviations

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model.
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Factor affecting the value chain.
  • 3.1.2 Profit margin analysis.
  • 3.1.3 Disruptions
  • 3.1.4 Future outlook
  • 3.1.5 Manufacturers
  • 3.1.6 Distributors
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing demand for vaccines and biologics
    • 3.2.1.2 Growth in biopharmaceutical industry
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High initial investment
    • 3.2.2.2 Supply chain Disruptions
• 3.3 Growth potential analysis
• 3.4 Future trend analysis
• 3.5 Price analysis
• 3.6 Technological landscape
• 3.7 Regulatory framework
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Company market share analysis
• 4.2 Competitive positioning matrix
• 4.3 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Equipment Type (USD Billion) (Thousand Units)

• 5.1 Key trends
• 5.2 Refrigerators
  • 5.2.1 Laboratory refrigerators
  • 5.2.2 Blood bank refrigerators
  • 5.2.3 Pharmacy refrigerators
  • 5.2.4 Chromatography refrigerators
• 5.3 Freezers
  • 5.3.1 Ultra-low temperature freezers
  • 5.3.2 Plasma freezers
  • 5.3.3 Shock freezers
• 5.4 Cryogenic storage systems
  • 5.4.1 Liquid nitrogen storage systems
  • 5.4.2 Vapor phase storage systems
• 5.5 Cold rooms
• 5.6 Others (ice lined refrigerators, solar direct drive refrigerators etc.)

Chapter 6 Market Estimates & Forecast, By Temperature Range (USD Billion) (Thousand Units)

• 6.1 Key trends
• 6.2 2°C to 8°C
• 6.3 -20°C to -40°C
• 6.4 -40°C to -80°C
• 6.5 Below -80°C

Chapter 7 Market Estimates & Forecast, By Capacity (USD Billion) (Thousand Units)

• 7.1 Key trends
• 7.2 Small (up to 300 liters)
• 7.3 Medium (300-700 liters)
• 7.4 Large (above 700 liters)

Chapter 8 Market Estimates & Forecast, By Technology (USD Billion) (Thousand Units)

• 8.1 Key trends
• 8.2 Compressor-based systems
• 8.3 Absorption-based systems
• 8.4 Thermoelectric-based systems

Chapter 9 Market Estimates & Forecast, By Application (USD Billion) (Thousand Units)

• 9.1 Key trends
• 9.2 Vaccine storage
• 9.3 Blood & blood products storage
• 9.4 Biological sample storage
• 9.5 Drug & pharmaceutical storage
• 9.6 Others (organ storage, cell culture media etc.)

Chapter 10 Market Estimates & Forecast, By End Use (USD Billion) (Thousand Units)

• 10.1 Key trends
• 10.2 Hospitals & clinics
• 10.3 Pharmaceutical companies
• 10.4 Research laboratories
• 10.5 Blood banks
• 10.6 Pharmacies
• 10.7 Others (academic institutions, diagnostic centers etc.)

Chapter 11 Market Estimates & Forecast, By Region (USD Billion) (Thousand Units)

• 11.1 Key trends, by region
• 11.2 North America
  • 11.2.1 U.S.
  • 11.2.2 Canada
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 France
  • 11.3.4 Italy
  • 11.3.5 Spain
• 11.4 Asia Pacific
  • 11.4.1 China
  • 11.4.2 India
  • 11.4.3 Japan
  • 11.4.4 Australia
  • 11.4.5 South Korea
• 11.5 Latin America
  • 11.5.1 Brazil
  • 11.5.2 Mexico
• 11.6 MEA
  • 11.6.1 Saudi Arabia
  • 11.6.2 UAE
  • 11.6.3 South Africa

Chapter 12 Company Profiles

• 12.1 Azenta
• 12.2 Binder
• 12.3 Cardinal Health
• 12.4 Carebios Biological Technology
• 12.5 Darwin Chambers
• 12.6 Elanpro
• 12.7 Farrar
• 12.8 Haier Biomedical
• 12.9 Hoshizaki America
• 12.10 Kendall Cold Chain System
• 12.11 Memmert
• 12.12 Philipp Kirsch
• 12.13 Roemer Industries
• 12.14 Summit Appliance
• 12.15 Thalheimer Kuhlung